Women in Biotech - Manchester
Wednesday 4 November 2020
We are very excited to bring the Women in Biotech series to Manchester for the first time in November 2020, though of course with the current situation this event will take place in virtual format.
Join us for an early evening event with networking and to hear from some inspiring women in our sector based in the Manchester area.
16.00 Registration and networking
16.30 Discussion and Q&A
Lisa Anson, CEO, Redx Pharma
Kath Mackay, Managing Director, Alderley Park
17:30 Closing remarks
17:35 Networking at virtual tables
19:00 Close of event
We are excited to bring you this Women in Biotech event in virtual format.
You will be able to join us online to network and, similar to an in-person event, move from virtual table to table to mingle with other attendees. The platform we will be using also includes useful features which will allow you to message directly with other attendees and share LinkedIn details to connect. There is also a general chat for all attendees.
During the panel discussion you will be able to submit and vote on audience questions and we will try our best to cover everything in the time allocated.
What are the technical requirements to attend the virtual event?
- There is no software installation or download required.
- Please attend using a laptop or desktop computer with audio and video capabilities (webcam and microphone). The mobile or tablet views are still in the beta stage.
- You will need to use one of the supported browsers to have the best user experience:
Chrome, Safari, or Firefox.
- If you want to check the technical requirements in more detail, you can view their checklist here.
If your company has firewalls or browsing restrictions in place, please test your connection and liaise with your IT team in advance to ensure you are able to fully participate in the event.
Lisa Anson is Chief Executive Officer of Redx Pharma plc, appointed 1 June 2018.
Lisa has been President of AstraZeneca UK since 2012 and has significant leadership experience in pharmaceuticals. Over a 20 year career at AstraZeneca plc, Lisa has held a number of senior management roles in both the US and the UK including Global Vice President, Oncology and as Vice President of emerging brands where she worked closely with the Research and Development teams.
Lisa holds an MBA (awarded with distinction) from INSEAD, France and a First Class honours degree in Natural Sciences from Cambridge University in the UK. Upon graduating she joined KPMG in London as a management consultant and then moved to California where she worked for Salick Health Care (now Aptium), a California based cancer disease management company, prior to joining Zeneca Pharmaceuticals (USA) in 1998 as a business development manager.
Lisa was President of the Association of the British Pharmaceutical Industry (ABPI) a position from which she will stepped down in July 2018. She has been a Board member of the ABPI since 2012 where she has chaired a number of UK industry committees and worked closely with Government and a wide range of industry stakeholders.
Jane joined the BIA in March 2016 as Director of Business Development and Membership Services, with overall responsibility for the recruitment and retention of members, development and delivery of membership services and BIA events.
Prior to this role and a short spell at the Food and Drink Federation assisting with membership development, she held the positions of Associate Director and Head of Sales & Marketing over a period of seven years at the Fire Protection Association – leading on membership and member events, publications, risk services, sales and marketing, CRM implementation and digital presence. Jane’s experience prior to this included Business Development Manager within tech transfer at Oxford Brookes University, four years at T&F/Informa Journals as Managing Editor and Publisher, and reference publishing at Oxford University Press and IBSS (International Bibliography of Social Sciences).
Jane holds a first degree in Italian and European Literature from Warwick University, an MA in Social Anthropology from SOAS, and an MBA from Oxford Brookes Business School.
The BIA’s Women in Biotech event series has been running for over 12 years and aims to connect, inspire, and support women across the sector.